Archive
Celebrating World IP Day with the Launch of the SickKids Technology Portfolio
Celebrating World IP Day with the Launch of the SickKids Technology Portfolio In celebration of World Intellectual Property (IP) Day this past weekend, the Industry Partnerships & Commercialization (IP&C) office at SickKids is proud to unveil our new online Technology Portfolio: a curated showcase of cutting-edge innovations developed by SickKids scientists, clinicians and researchers. Whether you're an industry partner, investor or academic collaborator, the Technology Portfolio offers new opportunities to connect with SickKids ideas and help bring them to life. Explore the Technology Portfolio From novel therapeutics to diagnostics and digital health solutions, these [...]
Dr. Jennifer Stinson Receives Gairdner Momentum Award for Transforming Paediatric Pain Care
AWARD ANNOUNCEMENT SickKids’ Dr. Jennifer Stinson Receives Gairdner Momentum Award for Transforming Paediatric Pain Care We’re thrilled to celebrate Dr. Jennifer Stinson, Nurse Practitioner, Senior Scientist, and long-time innovator at SickKids, as the recipient of the 2025 Peter Gilgan Canada Gairdner Momentum Award. Dr. Stinson is the first nurse to receive this award, which recognizes her leadership in transforming paediatric pain care through digital health. Her patient-partnered innovations are reshaping how we support children and teens living with chronic pain and complex conditions: iCanCope – A self-management app co-created with youth living with chronic [...]
SickKids’ Dr. Jayne Danska named UHN Inventor of the Year
AWARD ANNOUNCEMENT SickKids’ Dr. Jayne Danska named UHN Inventor of the Year for innovation in cancer immunotherapy The Industry Partnerships & Commercialization (IP&C) team is proud to congratulate Dr. Jayne Danska of The Hospital for Sick Children (SickKids), along with Drs. Jean Wang and John Dick of University Health Network (UHN) Princess Margaret Cancer Centre, on being named UHN’s Inventors of the Year! UHN recognized the team’s contributions to cancer immunotherapy last week at the UHN Mission Excellence Awards. This award celebrates outstanding achievements in commercialization and partnerships that drive UHN innovations forward—Danska, a Senior [...]
Winners of the 2024 Proof of Principle Grant Competition
FUNDING ANNOUNCEMENT Winners of the 2024 Proof of Principle Grant Competition Christine Bear Senior Scientist, Molecular Medicine Comparison of SickKids CFTR Potentiator to Ensifentrine in Ameliorating COPD in In-Vitro and In-Vivo Models Jayne Danska Senior Scientist, Genetics & Genome Biology Platform Conversion of Novel Antibody Biomarkers for Type 1 Diabetes and Patient Response to Preventative Immunotherapy Lynne Howell Senior Scientist, Molecular Medicine In Silico Designed Glycoside Hydrolases for Treatment of Biofilm Infections The [...]
SickKids Researcher Receives Commercialization Grant for Development of COPD Treatment
FUNDING ANNOUNCEMENT SickKids Researcher Receives Commercialization Grant for Development of COPD Treatment Dr. Christine Bear, Senior Scientist and Co-Director of the Cystic Fibrosis Centre at The Hospital for Sick Children (SickKids) and Professor at The University of Toronto, has been awarded $325,125 to support the commercialization of a novel treatment for chronic obstructive pulmonary disease (COPD). The funding was issued as part of the Canadian Institutes of Health Research (CIHR) Project Grant Program and is aimed at advancing discoveries towards effective health products and services. COPD is a common respiratory condition that affects approximately 300 million [...]
Radiant Biotherapeutics Secures $35 Million to Advance Multabody™ Therapeutics
FUNDING ANNOUNCEMENT Radiant Biotherapeutics Secures $35 Million to Advance Multabody™ Therapeutics Industry Partnerships & Commercialization (IP&C) is excited to share that Radiant Biotherapeutics has closed a $35 million USD series A financing co-led by the Bill & Melinda Gates Foundation and Amplitude Ventures. Radiant Biotherapeutics is a pharmaceutical company built upon the cutting-edge Multabody technology that was researched and developed by Dr. Jean-Philippe Julien at The Hospital for Sick Children (SickKids) and Dr. Bebhinn Treanor at the University of Toronto. By leveraging avidity and multi-specificity, Multabodies offer the potential to deliver [...]
